CMS COVERAGE FOR MEDICARE PRODUCT MEMBERSEFFECTIVE DATE: 02/21/01 REVISED DATE: 05/16/02, 06/16/05 ARCHIVED: 07/17/03-06/16/05, 03/16/06 EDITED DATE: 04/04/07, 04/17/08, 04/16/09, 04/22/10,04/21/11, 04/19/12, 04/18/13, 04/17/14,04/1...
CMS is expanding coverage for benefits that address social determinants of health, creating savings opportunities for payers and broadening opportunities for new entrants to healthcare. Medicare Advantage plans in 2019 will be able to provide coverage for a wider variety of non-medica...
noting limitations of the current Medicare Plan Finder Price Accuracy measure that is part of the Part C and D Star Ratings, including concerns that plans may be submitting artificially lower or high prices for the Medicare Plan Finder during the annual ...
CMS Issues Guidance to States on Children’s Access to Medicaid Coverage McDermott+on10/3/2024 Last week, the Center for Medicaid and CHIP Services within the Centers for Medicare & Medicaid Services (CMS) released what it calls “historic” guidance to states on best practices for adherence to...
On January 14, 2021, the Centers for Medicare & Medicaid Services (CMS) published a final rule1 that accomplishes two things: (1) speeding Medicare coverage of certain innovative devices and (2) codifying in regulations a definition of a "reasonable and necessary" item or service under the ...
Medicare Advantage (MA) organizations that use modern technology (such as artificial intelligence (AI)) to aid in making efficient coverage determinations are in the crosshairs of both Congress, which has held hearings and requested documents from MA organizations about AI and oth...
CMS' expanded ICD coverage is good for patients and industry.(Centers for Medicare & Medicaid Services; implantable cardioverter defibrillators) 来自 highbeam.com 喜欢 0 阅读量: 9 作者: C Delporte 收藏 引用 批量引用 报错 分享 全部来源 求助全文 highbeam.com 相似文献...
Objectives To review the various options that the Centers for Medicare & Medicaid Services (CMS) has to review new drugs and biologics under its National Coverage Determination (NCD) process, and conduct such review in the wake of its recent NCD for sipuleucel-T. This analysis seeks to better...
Centers for Medicare and Medicaid Services (CMS) to initiate a national coverage analysis of HIV screening under Medicare. The move comes after a CMS review of preventive services recommended by the U.S. Preventive Services Task Force. The task force strongly supports HIV screening for all ...
From a home care and hospice prospective, it is important that we understand what prescription drug plans are allowed and not allowed to market and promote to the Medicare beneficiary. It is also important that we know the parameters of any allowable telemarketing from companies offering ...